HPV vaccination package (3 doses of vaccine)
HPV vaccination package (3-dose schedule) for children aged 15 years and older and adults.
Buy cheaper - join MediClub and pay 10% less.

Medicover
- Product description
- Step by step purchase
- Important information
- Documents
Cervical cancer is one of the most common cancers in women. An important factor in its development is infection with HPV (Human Papillomavirus), as well as e.g. smoking, an unhealthy lifestyle or many natural births. There are more than 100 types of HPV - some of them can cause benign lesions, e.g. in the form of skin warts, others lead to the development of malignant tumours. HPV vaccination protects against these conditions.
Why is it worth getting vaccinated
Infection with certain types of HPV can lead to cervical cancer, genital warts (condyloma) and cancer of the larynx.
Only a few HPV subtypes are responsible for almost all cases of cervical cancer, primarily types 16 and 18, as well as 31, 33 and 45. These are viruses with a high oncogenic risk, i.e. favouring the development of cancer.
In contrast, HPV types with low oncogenic potential, such as 6 and 11, are the main cause of condyloma (i.e. the warts that appear on the genitals). HPV infection can also lead to cancers of the anus, mouth, throat, vagina, vulva, and penis.
Many people are unaware that they are carriers of the HPV virus. It can infect both men and women, and because it is often asymptomatic, infected people can unknowingly transmit it to their partners.
Infection occurs mainly through sexual contact, often at an early stage of sexual activity. Therefore, vaccination against HPV is most effective when done before intercourse begins.
It is estimated that up to 50-80% of sexually active people have had or will have contact with HPV during their lifetime.
Cervical cancer is one of the cancers that can be effectively prevented by the available preventive measures - vaccination and cytological examinations. Early detection of the disease allows for complete cure.
Vaccination against HPV stimulates the body to produce immunity, thus preventing infection. As a result, the risk of cervical cancer is significantly reduced.
Vaccination is recommended by the Minister of Health as part of the Immunisation Programme and recommended by the World Health Organisation (WHO), the European Centre for Disease Prevention and Control (CDC) and numerous scientific organisations in paediatrics, gynaecology and oncology.
HPV vaccine
The nine-valent HPV vaccine protects against nine types of the virus: 6, 11, 16, 18, 31, 33, 45, 52 and 58, seven of which are responsible for nearly 90% of cervical cancer cases.
The vaccine also prevents genital warts (condyloma) and cancers and precancerous lesions of the vulva, vagina, cervix and anus that can be caused by HPV infection.
Vaccine:
- is intended for children over 9 years of age and adults,
- administered at a young age protects against HPV for up to 50 years,
- administered up to the age of 14 years results in full immunization after only 2 doses, while 3 doses are needed for full immunization in persons over 15 years of age.
Vaccination schedule
The vaccination schedule depends on the age of the vaccinated person.
In adolescents over 15 years of age and adults, a 3-dose regimen applies: the second dose should be given at least one month after the first dose, and the third dose should be given at least 3 months after the second dose. All 3 doses should be given within 1 year.
The package includes:
- 3 doses of HPV vaccine,
- 3-fold administration of the vaccine.
Patients who do not have care at Medicover pay extra for vaccination eligibility visits, each time before the next dose is administered.